What are the major opportunities in the Lisinopril market? What are the strategies for the Lisinopril market?

For detailed insights on the major opportunities and strategies in the Lisinopril market, Read More

How does the Lisinopril market relate to the overall economy and other similar markets?

For detailed insights on Lisinopril's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Lisinopril market growth? SWOT analysis of the Lisinopril market.

For detailed insights on the key dynamics influencing the Lisinopril market growth and SWOT analysis of the Lisinopril industry, Read More

Lisinopril Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Lisinopril Market Report 2026

Name: Lisinopril Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Brand (Prinivil, Zestril, Other Brands), By Disease (Hypertension, Heart Failure, Heart Attack), By Dosage (Tablet, Liquid), By End-Users (Hospitals, Specialty Clinics) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Lisinopril Market Overview

• Lisinopril market size has reached to $1.87 billion in 2025

• Expected to grow to $2.47 billion in 2030 at a compound annual growth rate (CAGR) of 5.5%

• Growth Driver: Rising Cardiovascular Disease Rates Drive Expansion Of Lisinopril Market

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Lisinopril Market?

Lisinopril is a medication classified as an angiotensin-converting enzyme (ACE) inhibitor. It functions by reducing specific chemicals that constrict blood vessels, promoting smoother blood flow and enhancing the heart's ability to pump blood effectively. Lisinopril is prescribed to adults for the treatment of congestive heart failure and to increase survival rates following a heart attack.

The main types of brands are lisinopril zestoretic, prinivil, zestril, and others. Zestoretic is a medication containing a fixed blend of two active components such as lisinopril, which acts as an angiotensin-converting enzyme (ACE) inhibitor, and hydrochlorothiazide, a thiazide diuretic. The various diseases include hypertension, heart failure, heart attack, strokes, diabetic kidney disease, others with various dosages such as tablets, and liquid, and others with various population types including children, and adults. These are used by various end-users such as hospitals, specialty clinics, and others.

Lisinopril Market Global Report 2026 Market Report bar graph

What Is The Lisinopril Market Size and Share 2026?

The lisinopril market size has grown strongly in recent years. It will grow from $1.87 billion in 2025 to $1.99 billion in 2026 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to increasing incidence of hypertension, widespread clinical acceptance of ace inhibitors, growing aging population, early adoption in heart failure treatment, expansion of primary healthcare access.

What Is The Lisinopril Market Growth Forecast?

The lisinopril market size is expected to see strong growth in the next few years. It will grow to $2.47 billion in 2030 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to rising cardiovascular disease burden, growing demand for affordable generic drugs, increasing focus on preventive cardiac care, expansion of treatment in diabetic kidney disease, higher healthcare spending on chronic disease management. Major trends in the forecast period include rising prevalence of hypertension and cardiovascular disorders, growing reliance on ace inhibitors for first-line therapy, expansion of generic lisinopril prescriptions, increasing use in post-heart attack management, rising long-term treatment adherence in chronic care.

Book your 30 minutes free consultation with our research experts

Global Lisinopril Market Segmentation

1) By Brand: Prinivil, Zestril, Other Brands

2) By Disease: Hypertension, Heart Failure, Heart Attack

3) By Dosage: Tablet, Liquid

4) By End-Users: Hospitals, Specialty Clinics

Subsegments:

1) By Prinivil: Different Dosage Forms, Generic Versions Of Prinivil

2) By Zestril: Different Dosage Forms, Generic Versions Of Zestril

3) By Other Brands: International Brand Variants, Combination Drug Formulations

What Are The Drivers Of The Lisinopril Market?

The growing prevalence of cardiovascular diseases is expected to propel the growth of the lisinopril market going forward. Cardiovascular diseases (CVDs) encompass a range of disorders affecting the heart and blood vessels. The growing prevalence of cardiovascular diseases can be attributed to several factors, such as population growth and aging, risk factors, and lack of implementation of proven prevention and treatment strategies. Lisinopril helps manage cardiovascular diseases primarily through its ability to lower blood pressure and reduce the strain on the heart and kidneys. This inhibits the production of angiotensin II, facilitates the dilation of blood vessels, reduces blood volume, and protects organs from damage. For instance, in May 2024, according to the Singapore Heart Foundation (SHF), a Singapore-based non-profit organization, ischemic heart diseases resulted in 5,302 deaths, showing a slight increase from 5,290 deaths in 2022. Therefore, the growing prevalence of cardiovascular diseases is driving the growth of the lisinopril industry.

The increasing prevalence of hypertension is expected to propel the growth of the lisinopril market going forward. Hypertension, commonly known as high blood pressure, is a medical condition in which the force of the blood against the walls of the arteries is consistently too high. The rising prevalence of hypertension is due to an unhealthy diet, a sedentary lifestyle, an aging population, and long-term stress. Lisinopril is an effective medication for managing hypertension by blocking the formation of angiotensin II, leading to the relaxation of blood vessels, reduced blood volume, and lower blood pressure. For instance, in March 2023, The World Health Organization, a Switzerland-based health organization, around 1.28 billion adults aged 30–79 years worldwide had hypertension in 2023. Therefore, the increasing prevalence of hypertension drives the lisinopril industry.

Key Players In The Global Lisinopril Market

Major companies operating in the lisinopril market are Merck & Co. Inc., Pfizer Inc., Viatris Inc., Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Limited, Aurobindo Pharma Ltd., Cipla Inc., Hikma Pharmaceutical Plc, Apotex Inc., Amneal Pharmaceutical Inc., Lupin Ltd., Zydus Cadila Healthcare Ltd., Hetero Ltd., Dr. Reddy’s Laboratories Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Glenmark Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Mylan Pharmaceuticals Inc., Accord Healthcare Ltd., Sandoz International GmbH

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Lisinopril Market?

In January 2024, Sun Pharmaceutical Industries Limited, an Indian-based pharmaceutical company, acquired Taro Pharmaceutical Industries Ltd for $347.73 million. This acquisition marked sun pharma's move to expand its portfolio by incorporating Taro's expertise in providing generic and specialty medicines, active pharmaceutical ingredients (Apis), and over-the-counter products. Taro Pharmaceutical Industries Ltd. is a US-based company that offers lisinopril.

Regional Outlook

North America was the largest region in the lisinopril market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Lisinopril Market?

The lisinopril market consists of sales of prinivil, qbrelis, zestoretic, zestril and apo-lisinopril. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Lisinopril Market Report 2026?

The lisinopril market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the lisinopril industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Lisinopril Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$1.99 billion
Revenue Forecast In 2035	$2.47 billion
Growth Rate	CAGR of 6.2% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Brand, Disease, Dosage, End-Users
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Merck & Co. Inc., Pfizer Inc., Viatris Inc., Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Limited, Aurobindo Pharma Ltd., Cipla Inc., Hikma Pharmaceutical Plc, Apotex Inc., Amneal Pharmaceutical Inc., Lupin Ltd., Zydus Cadila Healthcare Ltd., Hetero Ltd., Dr. Reddy’s Laboratories Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Glenmark Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Mylan Pharmaceuticals Inc., Accord Healthcare Ltd., Sandoz International GmbH
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Lisinopril Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Lisinopril Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Lisinopril Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Lisinopril Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Prevalence Of Hypertension And Cardiovascular Disorders

4.2.2 Growing Reliance On Ace Inhibitors For First-Line Therapy

4.2.3 Expansion Of Generic Lisinopril Prescriptions

4.2.4 Increasing Use In Post-Heart Attack Management

4.2.5 Rising Long-Term Treatment Adherence In Chronic Care

5. Lisinopril Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Cardiology Clinics

5.4 Primary Care Centers

5.5 Retail Pharmacies

6. Lisinopril Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Lisinopril Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Lisinopril PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Lisinopril Market Size, Comparisons And Growth Rate Analysis

7.3. Global Lisinopril Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Lisinopril Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Lisinopril Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Lisinopril Market Segmentation

9.1. Global Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prinivil, Zestril, Other Brands

9.2. Global Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hypertension, Heart Failure, Heart Attack

9.3. Global Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Tablet, Liquid

9.4. Global Lisinopril Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinics, Cardiology Clinics, Primary Care Centers

9.5. Global Lisinopril Market, Sub-Segmentation Of Prinivil, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Different Dosage Forms, Generic Versions Of Prinivil

9.6. Global Lisinopril Market, Sub-Segmentation Of Zestril, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Different Dosage Forms, Generic Versions Of Zestril

9.7. Global Lisinopril Market, Sub-Segmentation Of Other Brands, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

International Brand Variants, Combination Drug Formulations

10. Lisinopril Market Regional And Country Analysis

10.1. Global Lisinopril Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Lisinopril Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Lisinopril Market

11.1. Asia-Pacific Lisinopril Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Lisinopril Market, Segmentation By Brand, Segmentation By Disease, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Lisinopril Market

12.1. China Lisinopril Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Lisinopril Market, Segmentation By Brand, Segmentation By Disease, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Lisinopril Market

13.1. India Lisinopril Market, Segmentation By Brand, Segmentation By Disease, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Lisinopril Market

14.1. Japan Lisinopril Market Overview

14.2. Japan Lisinopril Market, Segmentation By Brand, Segmentation By Disease, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Lisinopril Market

15.1. Australia Lisinopril Market, Segmentation By Brand, Segmentation By Disease, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Lisinopril Market

16.1. Indonesia Lisinopril Market, Segmentation By Brand, Segmentation By Disease, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Lisinopril Market

17.1. South Korea Lisinopril Market Overview

17.2. South Korea Lisinopril Market, Segmentation By Brand, Segmentation By Disease, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Lisinopril Market

18.1. Taiwan Lisinopril Market Overview

18.2. Taiwan Lisinopril Market, Segmentation By Brand, Segmentation By Disease, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Lisinopril Market

19.1. South East Asia Lisinopril Market Overview

19.2. South East Asia Lisinopril Market, Segmentation By Brand, Segmentation By Disease, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Lisinopril Market

20.1. Western Europe Lisinopril Market Overview

20.2. Western Europe Lisinopril Market, Segmentation By Brand, Segmentation By Disease, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Lisinopril Market

21.1. UK Lisinopril Market, Segmentation By Brand, Segmentation By Disease, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Lisinopril Market

22.1. Germany Lisinopril Market, Segmentation By Brand, Segmentation By Disease, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Lisinopril Market

23.1. France Lisinopril Market, Segmentation By Brand, Segmentation By Disease, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Lisinopril Market

24.1. Italy Lisinopril Market, Segmentation By Brand, Segmentation By Disease, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Lisinopril Market

25.1. Spain Lisinopril Market, Segmentation By Brand, Segmentation By Disease, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Lisinopril Market

26.1. Eastern Europe Lisinopril Market Overview

26.2. Eastern Europe Lisinopril Market, Segmentation By Brand, Segmentation By Disease, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Lisinopril Market

27.1. Russia Lisinopril Market, Segmentation By Brand, Segmentation By Disease, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Lisinopril Market

28.1. North America Lisinopril Market Overview

28.2. North America Lisinopril Market, Segmentation By Brand, Segmentation By Disease, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Lisinopril Market

29.1. USA Lisinopril Market Overview

29.2. USA Lisinopril Market, Segmentation By Brand, Segmentation By Disease, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Lisinopril Market

30.1. Canada Lisinopril Market Overview

30.2. Canada Lisinopril Market, Segmentation By Brand, Segmentation By Disease, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Lisinopril Market

31.1. South America Lisinopril Market Overview

31.2. South America Lisinopril Market, Segmentation By Brand, Segmentation By Disease, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Lisinopril Market

32.1. Brazil Lisinopril Market, Segmentation By Brand, Segmentation By Disease, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Lisinopril Market

33.1. Middle East Lisinopril Market Overview

33.2. Middle East Lisinopril Market, Segmentation By Brand, Segmentation By Disease, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Lisinopril Market

34.1. Africa Lisinopril Market Overview

34.2. Africa Lisinopril Market, Segmentation By Brand, Segmentation By Disease, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Lisinopril Market Regulatory and Investment Landscape

36. Lisinopril Market Competitive Landscape And Company Profiles

36.1. Lisinopril Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Lisinopril Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Lisinopril Market Company Profiles

36.3.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Teva Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Sun Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis

37. Lisinopril Market Other Major And Innovative Companies

Aurobindo Pharma Ltd., Cipla Inc., Hikma Pharmaceutical Plc, Apotex Inc., Amneal Pharmaceutical Inc., Lupin Ltd., Zydus Cadila Healthcare Ltd., Hetero Ltd., Dr. Reddy’s Laboratories Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Glenmark Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Mylan Pharmaceuticals Inc., Accord Healthcare Ltd.

38. Global Lisinopril Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Lisinopril Market

40. Lisinopril Market High Potential Countries, Segments and Strategies

40.1 Lisinopril Market In 2030 - Countries Offering Most New Opportunities

40.2 Lisinopril Market In 2030 - Segments Offering Most New Opportunities

40.3 Lisinopril Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Lisinopril Market, Overview Of Key Products - Product Examples

Table 2: Global Lisinopril Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Lisinopril Market, Supply Chain Analysis

Table 4: Global Lisinopril Market, Major Raw Material Providers

Table 5: Global Lisinopril Market, Major Resource Providers

Table 6: Global Lisinopril Market, Major Manufacturers (Suppliers)

Table 7: Global Lisinopril Market, Major Distributors And Channel Partners

Table 8: Global Lisinopril Market, Key Technologies & Future Trends

Table 9: Global Lisinopril Market, Major Trends

Table 10: Global Lisinopril Market, Major End Users

Table 11: Global Lisinopril Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Lisinopril Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Lisinopril Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Lisinopril Market - TAM, US$ Billion, 2025

Table 15: Global Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Lisinopril Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Lisinopril Market, Sub-Segmentation Of Prinivil, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Lisinopril Market, Sub-Segmentation Of Zestril, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Lisinopril Market, Sub-Segmentation Of Other Brands, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Lisinopril Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Lisinopril Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Lisinopril Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Lisinopril Market - Company Scoring Matrix

Table 98: Merck & Co. Inc. Financial Performance

Table 99: Pfizer Inc. Financial Performance

Table 100: Viatris Inc. Financial Performance

Table 101: Teva Pharmaceutical Industries Limited Financial Performance

Table 102: Sun Pharmaceutical Industries Limited Financial Performance

Table 103: Global Lisinopril Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Lisinopril Market, Competitive Dashboard

Table 105: Global Lisinopril Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Lisinopril Market Size Gain ($ Billion), Segmentation By Brand, 2025 – 2030

Table 107: Global, Lisinopril Market Size Gain ($ Billion), Segmentation By Disease, 2025 – 2030

Table 108: Global, Lisinopril Market Size Gain ($ Billion), Segmentation By Dosage, 2025 – 2030

List Of Figures

Figure 1: Global Lisinopril Market, Overview Of Key Products - Product Examples

Figure 2: Global Lisinopril Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Lisinopril Market, Supply Chain Analysis

Figure 4: Global Lisinopril Market, Major Raw Material Providers

Figure 5: Global Lisinopril Market, Major Resource Providers

Figure 6: Global Lisinopril Market, Major Manufacturers (Suppliers)

Figure 7: Global Lisinopril Market, Major Distributors And Channel Partners

Figure 8: Global Lisinopril Market, Key Technologies & Future Trends

Figure 9: Global Lisinopril Market, Major Trends

Figure 10: Global Lisinopril Market, Major End Users

Figure 11: Global Lisinopril Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Lisinopril Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Lisinopril Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Lisinopril Market - TAM, US$ Billion, 2025

Figure 15: Global Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Lisinopril Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Lisinopril Market, Sub-Segmentation Of Prinivil, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Lisinopril Market, Sub-Segmentation Of Zestril, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Lisinopril Market, Sub-Segmentation Of Other Brands, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Lisinopril Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Lisinopril Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Lisinopril Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Lisinopril Market - Company Scoring Matrix

Figure 98: Merck & Co. Inc. Financial Performance

Figure 99: Pfizer Inc. Financial Performance

Figure 100: Viatris Inc. Financial Performance

Figure 101: Teva Pharmaceutical Industries Limited Financial Performance

Figure 102: Sun Pharmaceutical Industries Limited Financial Performance

Figure 103: Global Lisinopril Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Lisinopril Market, Competitive Dashboard

Figure 105: Global Lisinopril Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Lisinopril Market Size Gain ($ Billion), Segmentation By Brand, 2025 – 2030

Figure 107: Global, Lisinopril Market Size Gain ($ Billion), Segmentation By Disease, 2025 – 2030

Figure 108: Global, Lisinopril Market Size Gain ($ Billion), Segmentation By Dosage, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Review key data-driven trends shaping the global data storage market in 2025.

Analyze the 6.7% CAGR growth trajectory and strategic trends shaping the global medical glass vaccine bottles market through 2029.

Lithium-Ion (Li-Ion) Market Report 2026 - Global Outlook – By Type ( Lithium Nickel Manganese Cobalt (LI-NMC), Lithium Iron Phosphate (LFP), Lithium Cobalt Oxide (LCO), Lithium Titanate Oxide (LTO), Lithium Manganese Oxi...

Seed Treatment Fungicides Market Report 2026 - Global Outlook – By Type (Synthetic Chemical, Biological), By Form (Liquid, Powder), By Crop Type (Cereals And Grains, Oilseeds And Pulses, Other Crop Types), By Application...

Robotic Smart Motors Market Report 2026 - Global Outlook – By Component (Hardware, Software), By Voltage (12V, 18V, 24V, 36V, 48V, Above 48V), By Robot Application Type (Industrial Robots, Service Or Commercial Robots, A...

Tobramycin Eye Drop Market Report 2026 - Global Outlook – By Product Type (Tobramycin Ophthalmic Suspension, Tobramycin And Dexamethasone Ophthalmic Suspension, Other Product Types), By Indication (Bacterial Eye Infectio...

Artificial Intelligence (Chipsets) Market Report 2026 - Global Outlook – By Hardware (Processor, Memory, Network), By Technology (Machine Learning, Natural Language Processing, Context-Aware Computing, Computer Vision, P...

Reporter Gene Assay Market Report 2026 - Global Outlook – By Product (Assay Kits, Reagents), By Application (Promoter Structural And Functional Analysis, Cell Signaling Pathways, Protein Interaction, Clinical And Gene Re...

Generative Artificial Intelligence (AI) Chipset Market Report 2026 - Global Outlook – By Type (Central Processing Unit (CPU), Graphics Processing Unit (GPU), Field-Programmable Gate Array (FPGA), Application-Specific Int...

Frequently Asked Questions

How big is the Lisinopril Market?

The Lisinopril market was valued at $1.87 billion in 2025, increased to $1.99 billion in 2026, and is projected to reach $2.47 billion by 2030.

What is the Lisinopril market growth?

The global Lisinopril market is expected to grow at a CAGR of 5.5% from 2026 to 2035 to reach $2.47 billion by 2035.

Who are the key players in Lisinopril market?

Some Key Players in the Lisinopril market Include, Merck & Co. Inc., Pfizer Inc., Viatris Inc., Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Limited, Aurobindo Pharma Ltd., Cipla Inc., Hikma Pharmaceutical Plc, Apotex Inc., Am

Major trend in this market includes: nan. For further insights on this market. request a sample here

North America was the largest region in the lisinopril market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lisinopril market report are Asia-Pacific, South East Asia, W

Book your 30 minutes free consultation with our research experts

Contact Us